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Abstract
There is wide interest in studying how the distribution of a continuous response changes
with a predictor. We are motivated by environmental applications in which the predictor
is the dose of an exposure and the response is a health outcome. A main focus in these
studies is inference on dose levels associated with a given increase in risk relative to a baseline.
Popular methods either dichotomize the continuous response or focus on modeling changes with
the dose in the expectation of the outcome. Such choices may lead to information loss and
provide inaccurate inference on dose–response relationships. We instead propose a Bayesian
convex mixture regression model that allows the entire distribution of the health outcome to
be unknown and changing with the dose. To balance flexibility and parsimony, we rely on a
mixture model for the density at the extreme doses, and express the conditional density at each
intermediate dose via a convex combination of these extremal densities. This representation
generalizes classical dose–response models for quantitative outcomes, and provides a more
parsimonious, but still powerful, formulation compared to nonparametric methods, thereby
improving interpretability and efficiency in inference on risk functions. A Markov chain Monte
Carlo algorithm for posterior inference is developed, and the benefits of our methods are
outlined in simulations, along with a study on the impact of ddt exposure on gestational
age.
Keywords: Additional risk; Benchmark dose; Conditional density estimation; Convex
density regression; Dose–response; Nonparametric density regression.
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1
1 Introduction
It is of substantial interest to study how the distribution of an outcome y ∈ Y varies with
a predictor x ∈ X ⊆ R. Focusing on the case in which Y ⊆ R, with the response variable
univariate and continuous, we let f(y|x) denote the conditional density of y given x. Our focus
is on environmental health studies in which x is the dose of a potentially adverse exposure,
and y defines a health response. In such studies there is a wide interest in relating dose to
the risk of an adverse health outcome, with such dose–response models forming the basis of
quantitative risk assessment and regulatory guidelines on safe levels of exposure (e.g. Piegorsch
and Bailer 2005, Chapter 4).
As a real–data illustrative application—which incorporates features common to different
observational dose–response studies—we focus on relating dde exposure in pregnant women
to the risk of a premature delivery (Longnecker et al. 2001). The data set is obtained from
a sub-study of the US Collaborative Perinatal Project (CPP), which was a large prospective
study of US pregnant women and their children. In this sub-study, dde, which is a persistent
metabolite of the pesticide ddt, was measured in the maternal serum during the third trimester
of pregnancy. dde is lipophilic and is stored in fat tissues, so that women build up a body
burden which could affect pregnancy.
Available risk assessment studies for these data rely on a Gaussian regression to infer
changes in gestational age with dde exposure, or leverage a logistic regression to study dde
effects on preterm birth, which coincides, typically, with a gestational age below 37 weeks.
Although these models are useful, according to the histograms in Figure 1, the Gaussian as-
sumption is unrealistic, whereas dichotomizing the data prior to inference leads to information
loss (e.g. West and Kodell 1999). In fact, to obtain a more complete and accurate characteri-
zation of risk it is necessary to estimate how the whole distribution of the gestational age at
delivery shifts with dde. We address this goal via a novel Bayesian convex mixture regression
(comire) model which allows the entire distribution of the gestational age to be unknown and
changing with dose. The proposed formulation combines mixture representations and convex
interpolations to balance flexibility and parsimony. This allows more accurate inference and
quantitative risk assessment compared to Gaussian regression, and improves efficiency along
with interpretability compared to fully nonparametric models.
1.1 Models and methods for quantitative risk assessment
In quantitative risk assessment one seeks to estimate the dose level associated with a given
small increase in risk of an adverse health event relative to the background risk corresponding
in general to zero dose. This estimated benchmark dose (BMDq) is useful in supporting
regulatory decisions, thus motivating inference on dose–response relationships to obtain the
BMDq—defined as the dose corresponding to a 100q% risk of an adverse health event above
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Figure 1: Histograms of the observed gestational age at delivery for selected dose intervals, along
with the pointwise posterior mean (continuous blue lines), and 95% credible intervals (shaded
blue areas) for f(y | x) calculated in the central points (7.5, 22.5, 37.5, 52.5, 67.5, 125) of each dose
interval, under the proposed convex mixture regression model. The figure appears in color in the
electronic version of this article.
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that for unexposed individuals.
Due to the abundance of dichotomous health data, the vast majority of the literature has
focused on discrete responses (e.g. Piegorsch et al. 2014; Fronczyk and Kottas 2014). There
has been instead less consideration of continuous outcomes. Earlier approaches dichotomize
the continuous response via a clinical threshold and then apply models for binary data (e.g.
Longnecker et al. 2001). From a statistical perspective, this leads to a loss of information,
efficiency, and validity compared to dose–response studies on the original scale of the data
(Crump 1995; West and Kodell 1999), thereby motivating a literature on quantitative risk
assessment modeling the continuous response on its original scale. Popular formulations as-
sume homoscedastic Gaussian responses with a dose–dependent expectation µ(x) commonly
defined as µ(x) = µ0 + (µ∞ − µ0)ψ(x;λ) for every x ∈ [0,∞), with µ0 and µ∞ denoting the
expectations of y at x = 0 and x → ∞, respectively, whereas ψ(x;λ) represents a monotone
nondecreasing dose–response function having ψ(0;λ) = 0, and ψ(x;λ) → 1 for x → ∞ (Ritz
et al. 2013, 2015). Other parametric models for µ(x) can be found in West and Kodell (1999);
Kodell and West (1993); Piegorsch et al. (2005).
Once the expectation µ(x) has been estimated, the excess risk above the background is
commonly measured via the additional risk function Ra(x, a) (Kodell and West 1993), which
is defined as
Ra(x, a) = pr(y ≤ a | x)− pr(y ≤ a | x = 0) = Fx(a)− F0(a), (1)
where a ∈ Y corresponds, in general, to a threshold of clinical interest, and Fx(a) = F (a | x) is
the conditional cumulative distribution function of the response at dose exposure x, computed
in the threshold a. In the absence of relevant clinical guidelines for the cutoff value a, it is
common practice to rely on tail values such as a = µ0−kσ with k = 2 or k = 3 (Kodell and West
1993; West and Kodell 1999; Piegorsch et al. 2005). Yu and Catalano (2005) consider instead
quantile regression, which avoids specification of a cutoff and incorporates heteroscedasticity
in Gaussian data. Based on (1), the BMDq of interest for inference is the solution of the
equation Ra(x, a) = q. Hence, differently from dichotomization strategies, the above methods
leverage the entire information in the data to learn Fx(a), and require a cutoff—e.g. a = 37
in our application—after the model has been estimated. According to (1), reliable inference
on Ra(x, a) and BMDq requires accurate learning of Fx(a), corresponding to an unknown
continuous conditional distribution.
Although the aforementioned methods facilitate tractable inference on Fx(a) and Ra(x, a),
the Gaussian assumption is difficult to justify in many toxicology studies. For example, as
shown in Figure 1, this assumption is violated in our illustrative data set, in terms of het-
eroscedasticity, skewness, and multimodality. Due to this, alternative contributions consider
mixtures of Gaussians, which improve flexibility while maintaining tractable inference in risk
assessments. Refer to Razzaghi and Kodell (2000), He et al. (2010), and Hwang and Pen-
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nell (2014) for relevant formulations. These models rely on a general specification for the
conditional density fx(y) = f(y | x), via
fx(y) =
H∑
h=1
νh(x)
1
σh
φ
{
y − µh(x)
σh
}
, (2)
where νh(x) is a probability weight for the h-th mixture component varying with x, and φ{·}
is the standard Gaussian density.
In performing inference under the above mixture model, Razzaghi and Kodell (2000)
consider a representation with H = 2 mixture components and fixed probability weights
νh(x) = νh for all x ∈ X . This choice is motivated by the nonresponse phenomenon in
dose–response studies (e.g. Good 1979), but H = 2 components may be insufficiently flexible
in many situations. An alternative possibility to address this issue is to fix H at a conservative
upper bound—potentially infinite—and allow the data to inform on the occupied number of
mixture components under a Bayesian framework. One example corresponds to the class of
anova dependent Dirichlet process (ddp) mixture models developed by De Iorio et al. (2004).
Although this formulation provides a more general alternative to a finite mixture model, there
are still flexibility issues associated with the assumption of constant probability weights. This
has motivated more flexible representations allowing the weights to change with x (e.g. Dun-
son and Park 2008; Rodriguez and Dunson 2011). Notable applications in quantitative risk
assessment inspired by these models can be found in He et al. (2010), and Hwang and Pennell
(2014). However, the increased flexibility of these methods comes at a cost in terms of inter-
pretability and parsimony in characterizing functionals of interest. This may lead to a loss of
efficiency, thereby increasing uncertainty in regulatory guidelines.
One possibility to improve upon these methods is to incorporate further structure, balanc-
ing interpretability, efficiency and flexibility. As described in Section 2, we address this goal
via comire. Our formulation interpolates two extremal densities f0(y) and f∞(y)—defined via
mixture models—through a single monotone increasing function β(x) ∈ [0, 1], which induces a
flexible, yet interpretable and parsimonious, characterization of fx(y). Although inference for
the statistical model outlined in Section 2 can proceed under different paradigms—including
the frequentist one—we focus here on a Bayesian implementation. This allows coherent un-
certainty quantification and tractable inference on relevant quantities for quantitative risk
assessment—such as the additional risk Ra(x, a), the BMDq, and more conservative bench-
mark doses BMDLq based on lower credible bounds of the BMDq (e.g. Crump 1995; Piegorsch
et al. 2005). These quantities are non-linear functions of the parameters, thereby requiring
asymptotic results and approximations for tractable frequentist inference. Under a Bayesian
approach, the posterior for these quantities can be obtained via Monte Carlo methods exploit-
ing the posterior samples of the parameters. Moreover, a Bayesian treatment allows formal
incorporation of prior knowledge and inclusion of relevant restrictions. This Bayesian imple-
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mentation is described in Section 3, and is compared against notable competitors on several
simulation experiments in Section 4. The CPP application is explored in Section 5, whereas
Section 6 contains concluding remarks and generalizations.
The code, data, and tutorial implementation of comire are available at github.com/
tonycanale/CoMiRe. Additional results and analyses can be found also in the Supplemen-
tary Materials.
2 Convex Mixture Regression
Let y ∈ Y ⊆ R. Our focus is on modeling the conditional density y | x ∼ fx(y) via the mixture
model
fx(y) = f(y | x) =
∫
Θ
K(y;θ)dPx(θ), (3)
where K(y;θ) is a kernel with support on Y and parametrized by θ ∈ Θ, whereas Px is a
mixing measure changing with x. Consistent with our focus, let X = R+. To clarify how
comire can be applied to many kernels, we avoid choosing a specific K(y;θ) for the moment.
Recalling Section 1.1, we look for a specification of Px which maintains a degree of flexibility
in modeling fx(y), while facilitating interpretable and efficient inference on relevant functionals
for quantitative risk assessment. We address this goal by assuming Px is a convex combination
of the two mixing measures P0 and P∞ at x = 0 and x→∞, respectively, obtaining
Px = {1− β(x)}P0 + β(x)P∞, x > 0, (4)
with β(x) a bounded monotone nondecreasing interpolation function having β(0) = 0 and
β(x)→ 1 as x→∞. Hence, changes in Px with x are controlled by a nondecreasing function
β(x) inducing a continuous shift in Px from P0 to P∞, as x grows. There are several ways to
define β(x) under the conditions of monotonicity—i.e β′(x) ≥ 0—and codomain constraints—
i.e. β(x) ∈ [0, 1]. A simple strategy to address this goal is to consider the basis expansion
β(x) =
J∑
j=1
wjψj(x), x > 0, (5)
where ψ1(x), . . . , ψJ(x) are monotone nondecreasing functions with ψj(x) ∈ [0, 1] for all j =
1, . . . , J . With this choice, the constraints on β(x) are translated into 0 ≤ wj ≤ 1 and
∑J
j=1wj = 1.
As will be clarified in Section 3, this facilitates Bayesian inference. A tractable default choice
for ψ1(x), . . . , ψJ(x), which is provably flexible in shape-constrained inference, is the I-splines
basis (Ramsay 1988). However, other specifications are possible, including general cumulative
distribution functions or classical dose–response functions (Ritz et al. 2013, 2015).
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To complete the specification of comire, we need a representation for the extreme mixing
measures P0 and P∞. In defining these quantities, we aim to preserve flexibility, while in-
corporating additional relevant structure available in quantitative risk assessment studies. In
particular, the predictor is the dose of a chemical having increasingly adverse health effects at
high values. Hence, as x grows, we expect the outcome to be centered on increasingly adverse
health profiles, meaning that E(y | x) = µ(x) is monotone decreasing with x, when adverse
health occurs for low values of y, as in our study. We include this adversity profile property
and flexibility in fx(y), by letting
P0 =
H∑
h=1
ν0hδθ0h , P∞ = δθ∞ , (6)
with δθ being the Dirac’s delta mass at point θ, H the total number of mixture components
in x = 0, and appropriate restrictions for the atoms, so that the single mixture component at
x→∞ is centered on a more adverse health profile than all the mixture components at x = 0,
obtaining
µ∞ < µ0h, for every h = 1, . . . ,H. (7)
In (7), µ∞ denotes the expectation of the single mixture component at the extreme dose range,
whereas µ0h is the expectation of the mixture component h characterizing the density at the
low end of the dose range, for every h = 1, . . . ,H. Leveraging representations (3)–(6), equation
(7) is sufficient to guarantee that fx(y) will shift to be centered on more adverse values of the
health response as dose x increases. Indeed, under (3)–(6), we obtain
E(y | x) = µ(x) = {1− β(x)}E(y | 0) + β(x)E(y | ∞)
= νᵀ0µ0 + (µ∞ − νᵀ0µ0)β(x), (8)
where ν0 = (ν01, . . . , ν0H)
ᵀ and µ0 = (µ01, . . . , µ0H)ᵀ are the vectors containing the mixing
weights and the expectations, respectively, of the components at the low end.
Although it is possible to relax (7) in various ways without affecting the monotonicity as-
sumption for µ(x), assuming the component at the high end of the dose range to be centered
on a more adverse health profile than all the components at the low end has appealing inter-
pretation in dose–response studies. Indeed, equation (7) implies that the single component at
the very high end of X corresponds to the most adverse health profile. Under (4) and (6), this
profile has probability zero and β(x), when x = 0 and x > 0, respectively. This assumption
interestingly incorporates common nonresponse effects in toxicology studies (Good 1979) by
allowing the exposed individuals to have a different degree β(x) of susceptibility to dose, which
increases with x. However, differently from current formulations (e.g. Razzaghi and Kodell
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2000), comire improves flexibility in modeling the nonresponders density f0(y) via a mixture
model accounting for possible adverse effects of unobserved chemicals. Since there is less in-
formation in the data to learn f∞(y), due to sparsity at high dose exposures, the responders
density is defined via a single kernel. Although this choice seems restrictive, in practice x→∞
is never observed and we do not attempt inference on fx(y) for very large x. This leads to
robustness to the assumptions in x → ∞, with fx(y) fully flexible at low dose and shifting
steadily towards being centered on more adverse values as x grows.
Generalizations to include more complex f∞(y) are possible. We attempted this extension
in initial analyses but observed no evident improvements. As we will outline in Sections 4 and
5, our basic comire leads to accurate results, and therefore we avoid complications affecting
interpretation.
2.1 Interpretation and properties
Model (3)–(4) has several interpretations worth exploring. A fundamental one for quantitative
risk assessment relates β(x) to the additional risk function Ra(x, a) = Fx(a)− F0(a) via
Ra(x, a) = {1− β(x)}F0(a) + β(x)F∞(a)− F0(a)
= β(x){F∞(a)− F0(a)}
= β(x)Ra(∞, a), (9)
where F0(a) = pr(y ≤ a | 0), and F∞(a) = pr(y ≤ a | ∞). According to (9), the benefit
associated with our representation, compared to the unstructured density regression models
discussed in Section 1.1, is that the effect of x enters only via the flexible function β(x) which
is proportional to Ra(x, a). Indeed, consistent with (9), the dose–response function β(x) can
be interestingly interpreted as a standardized additional risk at x with respect to an arbitrarily
high dose. In fact, β(x) = Ra(x, a)/Ra(∞, a). This allows inference on the BMDq, which is
available as the solution of the equation β(x) = q/Ra(∞, a), for each a ∈ Y and benchmark
risk q.
Besides the above interpretation, the formula for the conditional density fx(y) induced by
model (3)–(4) can be intuitively seen also as the result of a process which travels in distribution
between the starting location f0(y) and the ending one f∞(y), as time x increases from 0 to
∞, with β(x) denoting the proportion of the path traveled at time x. This metaphor eases
the interpretation of β(x), and is formally supported by Theorem 1 in the Supplementary
Materials.
To conclude the discussion on model interpretation and properties note that, consistent
with (8), the conditional expectation µ(x) of the health outcome y induced by our comire
coincides with the one characterizing popular dose–response models discussed in Section 1.1
(Ritz et al. 2013, 2015), after letting µ0 = ν
ᵀ
0µ0, ω1 = 1 and ψ1(x) = ψ(x;λ). At the
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same time, it is also clear that, while relaxing the Gaussian assumption, the proposed basis
expansion for β(x) in (5) is more flexible compared to the parametric dose–response functions
of routine use, thus generalizing the contributions of Wheeler and Bailer (2012) and Piegorsch
et al. (2014).
3 Bayesian Inference and Implementation
Consistent with our application and the dose–response models outlined in Section 1.1, we focus
on y ∈ Y ⊆ R, and let K(y;θ) = φ(y;µ, τ−1) be a Gaussian density with mean µ and variance
σ2 = τ−1, with θ = (µ, τ). This choice also facilitates quantitative risk assessment, provided
that, under the Gaussian assumption, F0(a) =
∑H
h=1 ν0hΦ{(a−µ0h)/σ0h} and F∞(a) = Φ{(a−
µ∞)/σ∞}.
Before describing the Markov chain Monte Carlo (MCMC) routine for posterior computa-
tion, we first include additional details on representations (3)–(6), and elicit the priors for each
unknown quantity. Let us first introduce the augmented data (bi, ci, di), for each i = 1, . . . , n,
with bi ∈ {1, . . . , J} indicating the basis function associated with unit i in (5), ci ∈ {1, . . . ,H}
its mixture component at the low end of the dose range according to (6), and di ∈ {0, 1} an
indicator for the membership to one of the two extreme mixing measures in (4). Conditioned
on these augmented data we can define the following hierarchical relations consistent with our
model:
{fxi(y) | di} = (1− di)f0(y) + dif∞(y), di ∼ Bern{β(xi)},
{β(xi) | bi = j} = ψj(xi), bi ∼ Cat(w1, . . . , wJ), (10)
{θi | ci = h, di = 0} = θ0h, ci ∼ Cat(ν01, . . . , ν0H),
where Cat(ρ1, . . . , ρp) denotes a categorical variable with probabilities (ρ1, . . . , ρp), Bern(ρ)
denotes a Bernoulli distribution with success probability ρ, while θ0h = (µ0h, τ0h). Marginal-
izing out the augmented data in (10), we obtain again (3), (5) and (6), under the convexity
assumption in (4). This augmented form is useful to develop the MCMC.
To conclude our Bayesian specification, we need to elicit prior distributions for the model
parameters, including the mixture weights in (6), the basis coefficients of β(x) in (5), and each
kernel-specific set of parameters. A natural prior for ν0 = (ν01, . . . , ν0H)
ᵀ at x = 0 is the
Dirichlet distribution Dir(α) with vector of hyperparameters α = (α1, . . . , αH). According to
Rousseau and Mengersen (2011), setting small values for the elements in α provides a flexible
prior for location-scale mixtures of Gaussians, which allows adaptive deletion of redundant
components. Following a similar reasoning we define a Dirichlet prior for the coefficients of
β(x) in (5), so that w = (w1, . . . , wJ)
ᵀ ∼ Dir(η), with small values for the hyperparameters
in η = (η1, . . . , ηJ). Finally, for the atoms θ0h = (µ0h, τ0h), h = 1, . . . ,H, and θ∞ = (µ∞, τ∞)
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characterizing the Gaussian kernels, we choose independent gamma priors Ga(aτ , bτ ) for the
precision parameters, and truncated Gaussian distributions for the locations µ0h, h = 1, . . . ,H
and µ∞, with mean µ ∈ R, variance κ > 0, and truncations meeting the adversity profile
property in (7), µ∞ < minh(µ0h).
Under the above prior specification, samples from the posterior distribution can be obtained
by sampling iteratively from the partially collapsed Gibbs sampler comprising the following
steps.
1. Update bi from the full conditional categorical random variable having probabilities
pr(bi = j | −) ∝ wj [{1− ψj(xi)}f0(yi) + ψj(xi)f∞(yi)],
for every j = 1, . . . , J .
2. Update w from the full conditional Dirichlet distribution
(w | −) ∼ Dir(η1 + n1, . . . , ηJ + nJ),
where nj is the number of subjects in which bi = j, and update β(x) by applying equation
(5).
3. Update di from
(di | −) ∼ Bern
[
β(xi)f∞(yi)
{1− β(xi)}f0(yi) + β(xi)f∞(yi)
]
.
4. For individuals with di = 0, update ci from the categorical variable having probabilities
equal to
pr(ci = h | −) ∝ ν0hφ(yi;µ0h, τ−10h ),
for every h = 1, . . . ,H.
5. Update the mixture weights ν0 characterizing P0 from
(ν0 | −) ∼ Dir (α1 + n1, . . . , αH + nH) ,
where nh is the number of units with di = 0, having ci = h.
6. Update each θ0h = (µ0h, τ0h), h = 1, . . . ,H under the restriction µ∞ < minh(µ0h), from
(µ0h | −) ∼ N(µˆh, σˆ2h, µ∞,+∞),
(τ0h | −) ∼ Ga(aˆh, bˆh),
where N(µ, σ2, a, b) denotes a Gaussian with mean µ, variance σ2, and truncated to the
interval (a, b). In the above equation, aˆh = aτ + nh/2, bˆh = bτ +
∑n
i=1 1I(di = 0, ci =
h)(yi − µ0h)2/2, σˆ2h = (κ−1 + nhτ0h)−1, µˆh = σˆ2h(κ−1µ + nhτ0hy¯h), and y¯h is the mean
of y for the units with di = 0 and ci = h. The term 1I(·) denotes, instead, the indicator
function.
10
7. Finally, update θ∞ = (µ∞, τ∞) under the restriction µ∞ < minh(µ0h), from
(µ∞ | −) ∼ N(µˆ∞, σˆ2∞,−∞,minh(µ0h)),
(τ∞ | −) ∼ Ga(aˆ∞, bˆ∞),
where aˆ∞ = aτ + n∞/2, bˆ∞ = bτ +
∑n
i=1 di(yi − µ∞)2/2, σˆ2∞ = (κ−1 + n∞τ∞)−1,
µˆ∞ = σˆ2∞(κ−1µ+ n∞τ∞y¯∞), y¯∞ =
∑n
i=1 diyi/n∞, and n∞ =
∑n
i=1 di.
This routine can be easily generalized to incorporate mixture models also for f∞(y) simply
modifying step (7), and adding a step similar to (4), to update the weights also at the high
end of X .
3.1 Goodness-of-fit via posterior predictive checks
To assess whether the restrictions of comire provide a good fit to the observed data un-
der the Bayesian framework, we perform posterior predictive checks (Gelman et al. 2014)
comparing relevant summary statistics computed from the observed data with their cor-
responding posterior predictive densities. Under comire, the posterior predictive density
fx(y) | (y1, x1), . . . , (yn, xn) from which the response data can be simulated is defined as∫ [
{1− β(x)}
H∑
h=1
ν0hτ0hφ{τ0h(y − µ0h)}+
β(x)τ∞φ{τ∞(y − µ∞)}
]
dΠ(ν0,θ0,θ∞,w | data),
(11)
where Π(ν0,θ0,θ∞,w | data) denotes the joint posterior distribution of the model parameters.
Although (11) is not analytically available, it is straightforward to simulate outcome data
y from the posterior predictive distribution in (11) by leveraging the MCMC samples of the
parameters and the hierarchical representation of the model in (10). Once these simulated data
sets are available, different summary statistics of interest can be computed, thus obtaining
samples from the corresponding posterior predictive distribution. If comire is not sufficiently
flexible for a specific study, we expect the observed summary statistics to fall in the tails
of their associated posterior predictive density. Since our main interest is in quantitative
risk assessment, we focus on comparing a smoothed empirical estimate of pr(y ≤ a | x) =
Fx(a) computed from the dichotomized sample data {1I(y1 ≤ a), x1}, . . . , {1I(yn ≤ a), xn},
with its posterior predictive density obtained from the replicated data sets generated from
(11). Although other statistics can be considered, according to (1), Fx(a) is the key function
underlying Ra(x, a), thus requiring careful model checking.
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(c) Scenario 3
Figure 2: Goodness-of-fit assessments for n = 500 in Scenario 1 (a), 2 (b), and 3 (c). Smoothed
empirical estimate of Fx(37) = pr(y ≤ 37 | x) computed from the observed data (black line), and
from 50 data sets simulated from the posterior predictive distribution induced by comire (grey
lines). In the x axis we also report the simulated dose exposures.
4 Simulation Experiments
To study the empirical performance of comire in providing inference for Ra(x, a) under several
data generative processes, we consider three simulations, covering correctly specified models
and model misspecification scenarios. To carefully assess performance in reasonable applied
settings, these scenarios are defined to incorporate relevant aspects of the motivating CPP
application and other related observational studies. These assessments involve two different
sample sizes: n = 2000 to mimic the CPP application, and n = 500 to evaluate performance
in smaller studies.
A common feature in observational dose–response studies is that the data are increasingly
sparse as the dose grows, with most of the individuals having reasonably low exposures to
adverse chemicals. We incorporate this feature by generating the doses xi, i = 1, . . . , n, from a
gamma distribution with a heavy right tail. These simulated doses range from 0 to about 132,
and have empirical quartiles 15.4, 24.9, 39.8 for the scenarios with n = 2000, and 11.2, 25.0,
48.2, for those with n = 500. For each unit, yi is generated under three different mechanisms
which maintain a similar range and structure to the one characterizing the observed gestational
age in the CPP data.
Scenario 1 covers the correctly specified setting and assumes the proposed comire model
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where the extreme density at x = 0 is a mixture of three Gaussian kernels having µ0 =
(37, 39, 40)ᵀ, ν0 = (0.05, 0.15, 0.80)ᵀ, and unit variances, whereas the density at x → ∞ is
a single Gaussian kernel with µ∞ = 36 and σ2∞ = 1. The β(x) function is assumed to be
the cumulative distribution function of a gamma random variable with shape 6 and rate 0.1.
Focusing on performance under model misspecification, we generate the data from a dependent
process but without comire specification in Scenario 2, and under an independent process in
Scenario 3. Specifically, Scenario 2 assumes a mixture of Gaussians with unit variances and
locations changing with x. The mixing weights are (0.10, 0.25, 0.65), whereas the locations
are µ1(x) = −x/300 + 35.5, µ2(x) = −x/50 + 38.5, and µ3(x) = −x/75 + 40.5, respectively.
Scenario 3 is instead a mixture of Gaussians with weights equal to (0.25, 0.25, 0.50), locations
(37, 39, 41), and unit variances.
In performing posterior inference, we set the hyperparameters following the guidelines in
Section 3. In particular we fix H = 10 for the number of mixture components at zero dose,
and set small values α1 = · · · = αH = 1/H in the Dirichlet prior for ν0 to allow adaptive
shrinkage. The function β(x) in (5) is instead defined via cubic I-splines with 7 equally-spaced
inner knots and 2 more at the extremes of the observed dose range—i.e. 0 and 132. The knot at
x = 0 incorporates the restriction β(0) = 0, whereas the one at 132 introduces a zero constant
function which allows asymptotes in β(x) at extreme doses. This choice provides J = 10 bases.
By considering small values η1 = · · · = ηJ = 1/J for the hyperparameters in the Dirichlet prior
for the I-splines coefficients w, we facilitate automatic learning of which bases are required to
flexibly characterize the dose–response function β(x). Finally, we center the mean parameters
in the Gaussian kernels on the empirical mean of the observed responses µ = y¯, and allow
moderate variations in the expectation of the different components by setting κ = 10. For the
hyperparameters in the component–specific variances we set instead aτ = bτ = 2 to allow a
moderate variability within each Gaussian kernel. To assess sensitivity we maintain the same
default hyperparameters settings in all the simulations.
Posterior inference relies on 5000 Gibbs iterations after a burn-in of 2000, and thinning the
chains every 5 samples. These settings were sufficient to obtain convergence and good mixing—
based on the traceplots and the Geweke’s diagnostic. The computations for each simulation
took ≈ 2′ and ≈ 6′ for n = 500 and n = 2000, respectively, under an R implementation on
a MacBook Pro with 2.8 GHz Intel i7 processor and 16 GB RAM. The following discussions
are related to the case n = 500. The results for n = 2000 are similar and reported in the
Supplementary Materials. It shall be also noticed that the following figures, including those
in Section 5 and in the Supplementary Materials, evaluate performance in a large dose range
avoiding excessively high exposures, which are unlikely to occur in the population and are not
of direct interest in quantitative risk assessments.
We study performance with a particular focus on recovering the true additional risk
Ra(x, a). However, before focusing on Ra(x, a), we first check model adequacy in Figure
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2, following the guidelines provided in Section 3.1. As is clear from Figure 2, our approach
provides adequate fit to the smoothed empirical estimate of Fx(37) = pr(y ≤ 37 | x) computed
from the observed data, thereby motivating inference on the additional risk Ra(x, a), with
a = 37. Note that these plots can detect lack of fit—for example, if the dose–response rela-
tion is non–monotone, or if there are evident differences between the generative process of the
observed data and the deflation–inflation mechanism of comire. In these situations, relaxing
comire restrictions under more flexible models is important to avoid bias. We shall however
emphasize that non–monotonicity of dose–response across the range of exposures faced by
humans in usual settings is rare. The most common type of non–monotonicity in these stud-
ies corresponds to down-turns at high doses—typically well beyond normal ranges of human
exposures. Similarly, evident departures from the comire assumptions, although possible, are
not frequent in observational dose–response studies. Hence, we focus on monotone relations,
and evaluate robustness to misspecification in reasonable scenarios.
To highlight the benefits of comire in providing inference on the additional risk, we compare
performance with the relevant competitors discussed in Section 1.1. In particular, we consider
a classical Gaussian regression with a Weibull dose–response function for µ(x) (Ritz et al.
2013, 2015), a more general formulation of the model in Razzaghi and Kodell (2000), via
anova–ddp with fixed weights (De Iorio et al. 2004), and, finally, a fully flexible dependent
mixture of Gaussians (f–dmix) including changes also in the mixing probabilities as in He
et al. (2010). These models are estimated with the R packages drc, DPpackage, and LSBP,
respectively. LSBP is a recent implementation of the probit stick–breaking by Rodriguez and
Dunson (2011), using the logistic link to improve computational performance without affecting
flexibility (Rigon and Durante 2017). In performing posterior inference under the anova–ddp
and the f–dmix, we consider routine implementations via linear functions of the predictor, and
set the hyperparameters using default choices which induce a comparable prior uncertainty
to comire. Figure 3 summarizes the posterior mean function and pointwise 95% posterior
credible bands for Ra(x, 37) obtained under comire, anova–ddp and f–dmix, in the three
scenarios. Results under the Weibull dose–response function were substantially inferior, and
therefore are not reported here.
The results in Figure 3 confirm our discussion in Section 1.1 on the different approaches
to inference in quantitative risk assessment. In particular, comire allows improved learning
of Ra(x, 37) in the correctly specified scenario, and has comparable performance to the more
flexible anova–ddp and f–dmix, in misspecified settings. As it can be noticed in the lower
panels of Figure 3, the estimation of Ra(x, 37) is particularly precise at low–dose exposures
x, where quantitative risk assessments typically focus. The reduced performance at high–dose
exposures is mainly due to sparsity in the data, thereby providing reduced information to
effectively estimate the parameters characterizing P∞. This result is also evident in Figure 2.
The anova–ddp provides accurate inference on Ra(x, 37) in Scenarios 2 and 3, where this
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Figure 3: Inference on the additional risk function for n = 500 in the three scenarios. The dashed
lines represent the true additional risk function Ra(x, 37), whereas the red, green, and blue con-
tinuous lines denote the posterior mean of Ra(x, 37) under anova–ddp, f–dmix, and comire,
respectively. The shaded areas represent the pointwise 95% posterior credible bands. In the x axis
we report the simulated dose exposures. Lower panels provide a zoom on the range of the additional
risk typically considered in benchmark dose analysis.
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model is correctly specified, but induces a notable bias in Scenario 1, possibly due to the
assumption of constant mixing weights. When relaxing this restriction under f–dmix, the bias
is reduced in Scenario 1. However, consistent with the discussion in Section 1.1, the increased
flexibility associated with f–dmix requires more parameters, thereby reducing efficiency. This
is evident in all the three scenarios, with f–dmix having higher posterior uncertainty than
comire, without substantially improving performance in estimating Ra(x, 37). According to
the lower panels in Figure 3, this reduced efficiency is evident for the common range (0, 0.1]
of the additional risk to be considered in benchmark dose analysis. These conclusions did not
change when considering other thresholds a different from 37.
Similar results also are discussed for n = 2000 in the Supplementary Materials. In this
case the higher sample size further reduces bias and posterior uncertainty—as expected.
5 Analysis of the CPP Data
We conclude by applying comire to infer changes in the gestational weeks at delivery with
dde, as discussed in Section 1. In particular, our focus is on n = 2312 women with gestational
ages less or equal than 45 weeks, since higher values are clear measurement errors. Posterior
inference is performed with the default hyperparameters and MCMC settings carefully de-
scribed in the tutorial implementation at github.com/tonycanale/CoMiRe. Also in this case
we obtain convergence and good mixing, with a runtime of ≈ 8′.
As outlined in Figures 1 and 4, comire provides an adequate fit to the observed data and the
associated functionals of interest, thus motivating inference and quantitative risk assessments.
According to Figure 1, the conditional density of the gestational age at delivery is far from
being Gaussian and displays variability, skewness and multimodality patterns changing with
dde. Indeed, at low–dose exposures most of the probability mass is concentrated around
normal pregnancies, with the posterior mean and the 95% credible interval for µ(0) being 40.20
and (40.01, 40.34). This is in line with results on normal gestational ages measured via last
menstrual periods, as in our application (Longnecker et al. 2001). In addition to these findings,
we also notice mild negative skewness, with a minor mode closer to overdue pregnancies,
and a tail towards preterm deliveries. As dde exposure grows, the negative skewness is still
maintained, but the tail towards preterm deliveries increasingly inflates until characterizing a
more evident mode centered on µ∞. The posterior mean and the 95% credible interval for the
latter quantity are 36.22 and (35.36, 36.94), respectively, thus providing evidence of preterm
pregnancy profiles at high–dose exposures.
These results clearly show that the negative association of dde with gestational age are
mostly on the shape, rather than on the trend. In particular, recalling the above discussion,
both adverse and non-adverse profiles are found across the predictor space, including at no dose
and high–dose exposures. What changes with dde is the degree β(x) of susceptibility to the
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Figure 4: Goodness-of-fit assessment in the application. Smoothed empirical estimate of Fx(37) =
pr(y ≤ 37 | x) computed from the observed data (black line), and from 50 data sets simulated from
the posterior predictive distribution induced by comire (grey lines). In the x axis we report the
observed exposures.
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Figure 5: Posterior mean (solid lines) and pointwise 95% credible bands (shaded areas) for (a)
β(x), (b) Ra(x, 37) and (c) the related BMDq. In the x axis in (a) and (b) we report the observed
exposures.
adverse effects of this chemical. In particular, the posterior mean and the 95% credible bands
of the β(x) function in panel (a) of Figure 5, show a notable increment in the probability of
the most adverse health profile at low–dose exposures. For instance, about 20% of the women
with a low dde concentration ≈ 20µg/l are expected to have a gestational age comparable to
women who had high dde exposures, with this profile being indicative of preterm pregnancies.
Consistent with the properties of comire discussed in Section 2.1, this percentage explicitly
measures in which proportion the additional risk at a given dde exposure relates to the one
associated with the worst health profile observed at an arbitrarily high dose without the need
to specify any threshold a for the negative health event.
For benchmark dose analyses, we consider the standard preterm threshold a = 37. Con-
sistent with Section 2.1, rescaling β(x) by Ra(∞, 37) provides the additional risk function
Ra(x, 37)—reported in panel (b) of Figure 5—inheriting the notable increment in the addi-
tional risk at low–dose exposures, which suggests conservative benchmark doses. The posterior
mean and the 95% credible bands for the BMDq—expressed as a function of q—confirm these
findings. In particular, as shown in panel (c) of Figure 5, the BMDq evolves on low values,
especially for the range of benchmark risks q ∈ {0.01, 0.05, 0.10} of interest in toxicology (e.g.
Piegorsch et al. 2005), thus implying the conservative policies on dde exposures in Table 1.
Motivated by interest in more conservative benchmark doses BMDLq relying on a lower confi-
dence bound of the BMDq, Table 1 provides also the BMDLq. Under our Bayesian approach to
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0.01 0.05 0.10
BMDq 1.03 [0.61, 2.62] 5.79 [3.50, 11.00] 15.29 [9.33, 25.41]
BMDLq 0.64 3.70 9.85
Table 1: For the three typical values of q, posterior mean and 95% credible intervals of the BMDq,
along with the BMDLq, characterizing the 5% quantile of the posterior distribution of the BMDq.
inference, such exposures can be obtained as the 5% lower quantile of the posterior distribution
of the BMDq, instead of requiring frequentist asymptotic approximations.
We also performed inference varying H to H = 5 and H = 15, but observed no relevant
differences in inference on Ra(x, 37), BMDq, and BMDLq.
6 Conclusion and Extensions
Motivated by quantitative risk assessment, we proposed a class of comires balancing flexibility
and parsimony in modeling conditional densities. Although the focus is on situations in which
the range of dose exposures is unbounded, comire can be applied also in studies when x
represents a concentration which is bounded above by xmax. In such settings, one appealing
possibility is to focus on the rescaled predictor x¯ = x/xmax ∈ [0, 1] and define each ψj(x¯) in
(5) via integrated Bernstein polynomials—i.e. Beta(j, 2J¯ − j + 1)—with J¯ = log2{J}. comire
can be also applied to binary health responses. In such settings it suffices to consider Bernoulli
kernels K(y;θ) = piy(1− pi)1−y, and let the extreme measures be P0 = δpi0 and P∞ = δpi∞ , to
obtain a fully flexible specification.
Consistent with our motivating application, we focus on the case in which lower outcome
values y are associated with adverse health. It is however straightforward to adapt the proposed
model to scenarios in which higher values of y are more adverse—e.g. blood cholesterol level.
It is also possible to control for the effect of additional covariates z, while maintaining the
adversity profile property in x. This can be done by allowing the location of each mixture
component to change also as a function g(z) of the additional covariates z. Using the same g(z)
within each component, the adversity profile property in x is maintained, and the additional
risk in x, for any z, is Ra(x, a; z) = β(x)Ra{∞, a; g(z)}, with Ra{∞, a; g(z)} the additional
risk at (∞, z). Note also that, although we focus on observational data, comire can be also
applied in experimental studies where units are exposed to pre–specified doses. In such settings,
comire will efficiently interpolate between the fixed doses. In contrast, fully unstructured
models, that attempt to infer the continuous dose–response relation from limited dose groups,
will tend to have wide uncertainty across the gaps between the pre–specified doses.
It is also interesting to incorporate U-shape behaviors for µ(x) at low dose exposures,
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which may occur in toxicology studies (e.g. Calabrese and Baldwin 2001). One possibility to
incorporate this property within comire is to introduce an intermediate mixing distribution
Pu at the central value xu corresponding to the minimum of the U-shape. Under appropriate
adversity profile restrictions for the atoms in P0, Pu and P∞, the U-shape can be incorporated,
including uncertainty in xu.
A Supplementary Material
Formal Interpretation of the β(x) Function
According to Section 2.1 of the paper, comire has several interpretations. Here, we formalize
the metaphor interpreting the conditional density fx(y) as the result of a process which travels
in distribution between the starting location f0(y) and the ending location f∞(y), as time x
increases from 0 to ∞. Theorem 1 clarifies the role of the β(x) function in measuring the
proportion of the path travelled at time x.
Theorem 1. Let F0(y), F∞(y), and Fx(y) characterize the probability distribution functions
inducing the density functions f0(y), f∞(y) and fx(y), respectively, in equations (3)–(4), and
let
dtv{F1(y), F2(y)} = 1
2
∫
|f1(y)− f2(y)|dy
be the total variation metric between the generic probability distribution functions F1(y) and
F2(y) inducing the densities f1(y) and f2(y). Then
β(x) = dtv{Fx(y), F0(y)}/dtv{F∞(y), F0(y)}.
Proof. Theorem 1, can be easily derived after noticing that∫
|fx(y)− f0(y)|dy =
∫
|{1− β(x)}f0(y) + β(x)f∞(y)− f0(y)|dy
= β(x)
∫
|f∞(y)− f0(y)|dy = 2β(x)dtv{F∞(y), F0(y)},
and therefore β(x) = dtv{Fx(y), F0(y)}/dtv{F∞(y), F0(y)}, thus proving Theorem 1.
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(a) Scenario 1
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Figure 6: Goodness-of-fit assessments for n = 2000 in Scenario 1 (a), 2 (b), and 3 (c). Smoothed
empirical estimate of Fx(37) = pr(y ≤ 37 | x) computed from the observed data (black line), and
from 50 data sets simulated from the posterior predictive distribution induced by comire (grey
lines). In the x axis we also report the simulated dose exposures.
Additional Simulation Results
Here, we reproduce the performance assessments of Section 4 in the paper under the same
scenarios, simulation settings, prior specifications, and competing methods, but focusing on a
larger sample involving n = 2000 units, instead of n = 500. This situation mimics the sample
size available in the CPP application. Refer to Section 4 for details on the three scenarios,
prior specifications, and competing methods.
Consistent with the performance assessments in Section 4, we first check model adequacy
in Figure 6 and then focus on evaluating inference for Ra(x, a) in Figure 7. According to
Figure 6, also for n = 2000, our approach provides adequate fit to the smoothed empirical
estimate of Fx(37) = pr(y ≤ 37 | x) based on the observed data in all the three scenarios.
This motivates inference on the additional risk, whose quality is compared with the relevant
competitors anova–ddp and f–dmix in Figure 7.
The results in Figure 7 are in line with those discussed for n = 500 in Section 4 of the
paper. Specifically, comire allows accurate learning of Ra(x, 37) both in the correctly specified
scenario, and in the cases of model misspecification. The estimation of Ra(x, 37) is particularly
precise at low–dose exposures, where quantitative risk assessments typically focus, as can be
seen from the bottom panels of Figure 7. As expected, the increased simple size allows further
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(a) Scenario 1
| ||| ||||| | | || || |||| | || | | ||| || |||| || || || || | || || | |||| || ||| || || ||| | || || || || | ||| || || ||| | || ||| ||| | || | | ||| || ||| | |||| || | | || || | | || | || | | | || || | || |||| ||| || |||| || ||| || ||| || | | ||| ||| || || ||| || || || | ||| ||| |||| ||| || || ||| || ||| | | ||| | ||| || | || || | ||||| | | || || || || | || | | ||| || || | ||| | || || |||| || || | | ||| |||| || || || ||| || || | || || | ||| | || || | || | | || | ||| || ||||| || || |||| ||| |||| || | | || | || || | |||| | ||| | || ||| ||| | || || | || || ||| || | || || | || || | ||| || | ||| | |||| ||| || ||| || || ||| ||| || || |||| || | ||| | ||| || ||| || ||| | | |||| ||| | |||| | || | | || || | | || || || || | || || || | || | || |||| || || || ||||| | ||||| || | || ||| | | |||| | ||| | || | || | ||| ||| || | || || || ||| | | || | | || ||| ||| || | ||||| | || | || | | |||| |||| || || | | || || || || || | || | | ||| || | || || || ||| || || | | | || || ||| |0.0
0.2
0.4
0.6
0.8
0 25 50 75 100
x
R
A(x
, 
37
)
0.0
0.1
0 5 10 15 20 25
x
R
A(x
, 
37
)
(b) Scenario 2
| ||| ||||| | | || || |||| | || | | ||| || |||| || || || || | || || | |||| || ||| || || ||| | || || || || | ||| || || ||| | || ||| ||| | || | | ||| || ||| | |||| || | | || || | | || | || | | | || || | || |||| ||| || |||| || ||| || ||| || | | ||| ||| || || ||| || || || | ||| ||| |||| ||| || || ||| || ||| | | ||| | ||| || | || || | ||||| | | || || || || | || | | ||| || || | ||| | || || |||| || || | | ||| |||| || || || ||| || || | || || | ||| | || || | || | | || | ||| || ||||| || || |||| ||| |||| || | | || | || || | |||| | ||| | || ||| ||| | || || | || || ||| || | || || | || || | ||| || | ||| | |||| ||| || ||| || || ||| ||| || || |||| || | ||| | ||| || ||| || ||| | | |||| ||| | |||| | || | | || || | | || || || || | || || || | || | || |||| || || || ||||| | ||||| || | || ||| | | |||| | ||| | || | || | ||| ||| || | || || || ||| | | || | | || ||| ||| || | ||||| | || | || | | |||| |||| || || | | || || || || || | || | | ||| || | || || || ||| || || | | | || || ||| |0.0
0.2
0.4
0.6
0.8
0 25 50 75 100
x
R
A(x
, 
37
)
0.0
0.1
0 5 10 15 20 25
x
R
A(x
, 
37
)
(c) Scenario 3
Figure 7: Inference on Ra(x, 37) for n = 2000 in the three scenarios. The dashed lines represent the
true additional risk function, whereas the red, green, and blue continuous lines denote the posterior
mean of the additional risk under anova–ddp, f–dmix, and comire, respectively. The shaded
areas represent the pointwise 95% posterior credible bands. In the x axis we report the simulated
dose exposures. Lower panels provide a zoom on the range of the additional risk typically considered
in benchmark dose analysis.
improvements in posterior accuracy and precision for Ra(x, 37) compared to the situation in
which n = 500.
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Code, Data and Tutorial Implementation
Code, data and a tutorial implementation of comire in the CPP application are available at
github.com/tonycanale/CoMiRe.
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